Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01026077 · ClinicalTrials.gov registry record
The Savella Pregnancy Registry
A clinical trial, sponsored by Syneos Health.
- Terminated
- Registry status
- 350
- Enrollment target
NCT01026077: Clinical Trial study, sponsored by Syneos Health.
NCT01026077 is a clinical trial that was terminated before completion, run by Syneos Health. The registered enrollment target is 350 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01026077 was terminated before completion, sponsored by Syneos Health.
- TERMINATED
- Registry status
- 350 participants
- Enrollment target
Study Summary
The Savella Pregnancy Registry is a US based registry designed to monitor pregnancies exposed to Savella (milnacipran HCI). This is an observational, exposure-registration and follow-up registry designed primarily to estimate the prevalence of major congenital anomalies, and secondarily to estimate the prevalence of recognized spontaneous abortions, stillbirths, induced abortions, minor congenital anomalies, and any serious adverse pregnancy outcomes among pregnancies exposed to Savella as well as adverse outcomes observed during the first year of life in off-springs born from these exposed pregnancies. Live offspring are followed from birth until age one. The Savella Pregnancy Registry is sponsored by AbbVie (formerly Actavis PLC, Forest Laboratories Inc., and Allergan) and managed by Syneos Health.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2009-11 |
| Est. Completion | 2024-10-09 |
Why NCT01026077 stopped before completion
NCT01026077 is an observational study that tracks outcomes without assigning an intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01026077 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01026077 about?
NCT01026077 is a clinical study titled "The Savella Pregnancy Registry". The Savella Pregnancy Registry is a US based registry designed to monitor pregnancies exposed to Savella (milnacipran HCI). This is an observational, exposure-registration and follow-up registry designed primarily to estimate the prevalence of major congenital anomalies, and secondarily to estimate ...
What is the current status of trial NCT01026077?
This trial is currently terminated. The enrollment target is 350 participants. The study started on 2009-11. Estimated completion is 2024-10-09.
Who is sponsoring clinical trial NCT01026077?
This trial is sponsored by Syneos Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia